Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism in Patients With Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03139487
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:27.543630+00:00
Published At
2020-01-06T00:00:00+00:00
Record Updated At
2020-01-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cancer-associated Thrombosis", "Esophageal Cancer", "Stomach Cancer", "Hepatocellular Carcinoma", "Pancreatic Cancer", "Duodenal Cancer", "Esophagogastric Junction Cancer", "Malignant Gastrointestinal Stromal Tumor", "Ampulla of Vater Cancer", "Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-01-06"
protocolSection.identificationModule.nctId
"NCT03139487"
protocolSection.identificationModule.officialTitle
"A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism in Patients With Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Cancer-associated Thrombosis (protocolSection.conditionsModule.conditions)
  • Esophageal Cancer (protocolSection.conditionsModule.conditions)
  • Stomach Cancer (protocolSection.conditionsModule.conditions)
  • Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)
  • Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Duodenal Cancer (protocolSection.conditionsModule.conditions)
  • Esophagogastric Junction Cancer (protocolSection.conditionsModule.conditions)
  • Malignant Gastrointestinal Stromal Tumor (protocolSection.conditionsModule.conditions)
  • Ampulla of Vater Cancer (protocolSection.conditionsModule.conditions)
  • Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.